Patents by Inventor Rick Rinck

Rick Rinck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Angiotensin type 2 (AT2) receptor agonists and uses thereof
    Patent number: 9707268
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 18, 2017
    Assignee: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof
    Publication number: 20160220632
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll